Shelley Margetson
Managing Partner at V-Bio Ventures
About
Joined V-Bio Ventures in 2020 and brings over 20 years of executive experience in finance and business across European biotechnology companies. She served as CFO during Merus' Nasdaq IPO and as CEO of Gadeta, managing funding rounds and strategic exits.
Colleagues at V-Bio Ventures
Christina Takke
Managing Partner at V-Bio Ventures
Dr. Loïc Laplanche
Chief Operating Officer at V-Bio Ventures
Dr. Marie-Laurence Gourlay-Chu
Chief Medical Officer at V-Bio Ventures
Katja Rosenkranz
Partner at V-Bio Ventures
Martin Solleveld
Finance Manager at V-Bio Ventures
Mathias Falcenberg
Venture Partner at V-Bio Ventures
Tom Schwarz
Strategic Advisory Board Member at V-Bio Ventures
Ward Capoen
Partner at V-Bio Ventures